Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott, Glaxo Bidding In India For Wockhardt's Nutrition Brands

This article was originally published in The Tan Sheet

Executive Summary

Abbott Laboratories and GlaxoSmithKline could be sizing up Indian firm Wockhardt's nutritionals business, with products including Protinex health supplements and Farex, Dexolac and Nusobee pediatric nutrition brands, as a cog for emerging market growth.
Advertisement

Related Content

Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost
Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost
Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost
Abbott Gives Nutritionals More Visibility To Highlight Diversity
Abbott Gives Nutritionals More Visibility To Highlight Diversity
GSK Divests Non-Core OTCs To Focus On "Priority Brands," Emerging Markets
Sales & Earnings In Brief
Nepentes Buy Continues Sanofi Consumer Product Acquisition March
Abbott, Wockhardt Terminate Nutritional Business Deal
Abbott, Wockhardt Terminate Nutritional Business Deal

Topics

Advertisement
UsernamePublicRestriction

Register

PS104887

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel